volume 19 issue 4 pages 262-279

Pharmacokinetics and Pharmacodynamics of Curcumin-Loaded Solid Lipid Nanoparticles in the Management of Streptozotocin-Induced Diabetes Mellitus: Application of Central Composite Design

Publication typeJournal Article
Publication date2021-05-02
scimago Q3
wos Q3
SJR0.308
CiteScore3.3
Impact factor1.7
ISSN1540658X, 15578127
PubMed ID:  34000202
Drug Discovery
Molecular Medicine
Abstract
Due to poor bioavailability and chemical instability, the effectiveness of curcumin is negligible in the treatment of numerous diseases. Solid lipid nanoparticles (SLNs) increase the bioavailability of lipophilic compounds and protect the drug from gastrointestinal degradation. The objective of our study is the utilization of SLNs to improve the pharmacokinetics and pharmacodynamics of curcumin in the management of diabetes mellitus. Central composite design was used to prepare curcumin-loaded SLNs (Cur-SLN). The analysis of independent variables like drug concentration, lipid concentration, and surfactant concentration was carried out using analysis of variance (ANOVA) to obtain the optimized batch (optimized Cur-SLN) having the desired values of dependent variables particle size and entrapment efficiency. In vitro release, differential scanning calorimeter (DSC), transmission electron microscopy (TEM), and Fourier Transform Infra-Red (FTIR) studies of optimized Cur-SLN were carried out and then its pharmacokinetic and pharmacodynamic studies were performed. The model was found to be significant for particle size and entrapment efficiency based on F-value and p-value. The optimized batch's predicted values were in close agreement with the actual values of particle size and entrapment efficiency. TEM results confirm mono-dispersion and spherical shape of particles in the formulation. The DSC results confirmed the changing of drug from crystalline to amorphous form. Burst release followed by the sustained release was obtained in the in vitro release studies. The pharmacokinetic study shows enhanced bioavailability of optimized Cur-SLN compared with a plain drug suspension. The optimized Cur-SLN achieved higher antidiabetic activity in streptozotocin-induced diabetes mellitus rats than the plain drug suspension. SLNs can be used as a promising technique for delivering curcumin in the management of diabetes mellitus.
Found 
Found 

Top-30

Journals

1
Nanoscience and Nanotechnology - Asia
1 publication, 5.26%
Drug Delivery
1 publication, 5.26%
Pharmaceuticals
1 publication, 5.26%
Metabolic Brain Disease
1 publication, 5.26%
Journal of Cluster Science
1 publication, 5.26%
Biomaterials Advances
1 publication, 5.26%
Biomedicine and Pharmacotherapy
1 publication, 5.26%
International Journal of Nanomedicine
1 publication, 5.26%
Drug Delivery Letters
1 publication, 5.26%
Studies in Natural Products Chemistry
1 publication, 5.26%
Saudi Pharmaceutical Journal
1 publication, 5.26%
Asian Journal of Pharmaceutical Research and Health Care
1 publication, 5.26%
Food Chemistry
1 publication, 5.26%
Russian Chemical Reviews
1 publication, 5.26%
Intelligent Pharmacy
1 publication, 5.26%
Journal of Drug Targeting
1 publication, 5.26%
ChemMedChem
1 publication, 5.26%
Advances in Science, Technology & Innovation
1 publication, 5.26%
1

Publishers

1
2
3
4
5
Elsevier
5 publications, 26.32%
Taylor & Francis
3 publications, 15.79%
Springer Nature
3 publications, 15.79%
Bentham Science Publishers Ltd.
2 publications, 10.53%
MDPI
1 publication, 5.26%
King Saud University
1 publication, 5.26%
Medknow
1 publication, 5.26%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 5.26%
Wiley
1 publication, 5.26%
1
2
3
4
5
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
19
Share
Cite this
GOST |
Cite this
GOST Copy
Sharma J. et al. Pharmacokinetics and Pharmacodynamics of Curcumin-Loaded Solid Lipid Nanoparticles in the Management of Streptozotocin-Induced Diabetes Mellitus: Application of Central Composite Design // Assay and Drug Development Technologies. 2021. Vol. 19. No. 4. pp. 262-279.
GOST all authors (up to 50) Copy
Sharma J., Bhatt S., Saini V., Kumar M. Pharmacokinetics and Pharmacodynamics of Curcumin-Loaded Solid Lipid Nanoparticles in the Management of Streptozotocin-Induced Diabetes Mellitus: Application of Central Composite Design // Assay and Drug Development Technologies. 2021. Vol. 19. No. 4. pp. 262-279.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1089/adt.2021.017
UR - https://doi.org/10.1089/adt.2021.017
TI - Pharmacokinetics and Pharmacodynamics of Curcumin-Loaded Solid Lipid Nanoparticles in the Management of Streptozotocin-Induced Diabetes Mellitus: Application of Central Composite Design
T2 - Assay and Drug Development Technologies
AU - Sharma, J.
AU - Bhatt, Shailendra
AU - Saini, Vipin
AU - Kumar, Manish
PY - 2021
DA - 2021/05/02
PB - Mary Ann Liebert
SP - 262-279
IS - 4
VL - 19
PMID - 34000202
SN - 1540-658X
SN - 1557-8127
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2021_Sharma,
author = {J. Sharma and Shailendra Bhatt and Vipin Saini and Manish Kumar},
title = {Pharmacokinetics and Pharmacodynamics of Curcumin-Loaded Solid Lipid Nanoparticles in the Management of Streptozotocin-Induced Diabetes Mellitus: Application of Central Composite Design},
journal = {Assay and Drug Development Technologies},
year = {2021},
volume = {19},
publisher = {Mary Ann Liebert},
month = {may},
url = {https://doi.org/10.1089/adt.2021.017},
number = {4},
pages = {262--279},
doi = {10.1089/adt.2021.017}
}
MLA
Cite this
MLA Copy
Sharma, J., et al. “Pharmacokinetics and Pharmacodynamics of Curcumin-Loaded Solid Lipid Nanoparticles in the Management of Streptozotocin-Induced Diabetes Mellitus: Application of Central Composite Design.” Assay and Drug Development Technologies, vol. 19, no. 4, May. 2021, pp. 262-279. https://doi.org/10.1089/adt.2021.017.